Thanks for the article, toby. It makes sense now as to why M&G continued to buy, and why some mob added to the placement at way above current price levels.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025